Mason Street Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,296
Closed -$255K 687
2020
Q4
$255K Sell
6,296
-3
-0% -$107 ﹤0.01% 1365
2020
Q3
$205K Buy
6,299
+87
+1% +$2.61K ﹤0.01% 1339
2020
Q2
$164K Buy
6,212
+502
+9% +$13.1K ﹤0.01% 1382
2020
Q1
$142K Hold
5,710
﹤0.01% 1350
2019
Q4
$205K Buy
5,710
+184
+3% +$6.35K ﹤0.01% 1381
2019
Q3
$189K Buy
5,526
+207
+4% +$6.61K ﹤0.01% 1380
2019
Q2
$149K Buy
5,319
+225
+4% +$6.25K ﹤0.01% 1418
2019
Q1
$158K Buy
5,094
+168
+3% +$4.48K ﹤0.01% 1458
2018
Q4
$116K Buy
4,926
+255
+5% +$6.96K ﹤0.01% 1435
2018
Q3
$181K Buy
4,671
+265
+6% +$9.55K ﹤0.01% 1401
2018
Q2
$148K Buy
4,406
+184
+4% +$6.55K ﹤0.01% 1439
2018
Q1
$153K Buy
4,222
+264
+7% +$9.14K ﹤0.01% 1403
2017
Q4
$126K Buy
3,958
+152
+4% +$5.21K ﹤0.01% 1424
2017
Q3
$142K Buy
3,806
+698
+22% +$23.8K ﹤0.01% 1394
2017
Q2
$97K Buy
+3,108
New +$89.8K ﹤0.01% 1445

Other funds holding LMAT

Mason Street Advisors's LMAT Position: Q1 2021 in Review

Mason Street Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 6,296 shares — an estimated $255K sold.

Mason Street Advisors first reported a position in LMAT in Q2 2017 and held it in 15 quarters. The position peaked at $255K in Q4 2020. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

  • Mason Street Advisors reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 6,296 LeMaitre Vascular shares in Q1 2021, an estimated $255K.
  • Mason Street Advisors first reported a position in LeMaitre Vascular in Q2 2017 and held it in 15 quarters.
  • Mason Street Advisors's LeMaitre Vascular position peaked at $255K in Q4 2020.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.